Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-19 Purchase |
2024-11-20 4:20 pm |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
666,666 | $2.25 | $1,499,999 | 710,030 (Direct) |
View |
| 2024-08-02 Purchase |
2024-08-05 3:57 pm |
Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner |
373,569 | $1.2655 | $472,757 | 14,250,000 (Indirect) |
View |
| 2024-07-30 Purchase |
2024-07-31 4:10 pm |
Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner |
273,730 | $1.3115 | $359,010 | 13,876,421 (Indirect) |
View |
| 2024-07-18 Purchase |
2024-07-22 4:03 pm |
Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner |
154,722 | $1.3043 | $201,808 | 13,602,691 (Indirect) |
View |
| 2024-07-02 Purchase |
2024-07-05 2:46 pm |
Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner |
352,397 | $1.1518 | $405,894 | 13,447,969 (Indirect) |
View |
| 2024-06-27 Purchase |
2024-07-01 1:39 pm |
Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner |
1,543,434 | $1.1287 | $1,742,075 | 13,095,572 (Indirect) |
View |
| 2024-06-14 Purchase |
2024-06-18 4:04 pm |
Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner |
545,000 | $1.1527 | $628,206 | 11,552,134 (Indirect) |
View |
| 2024-06-11 Purchase |
2024-06-13 6:04 pm |
Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner |
1,611,200 | $1.1059 | $1,781,897 | 11,007,134 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Exercise |
2025-04-03 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO |
9,467 | $0 | 1,482,799 (Direct) |
View |
| 2025-04-01 Tax Withholding |
2025-04-03 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO |
3,042 | $1.48 | 1,482,799 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
727 | $1.99 | 94,983 (Direct) |
View |
| 2025-03-01 Exercise |
2025-03-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
3,475 | $0 | 94,983 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO |
3,277 | $1.99 | 1,485,841 (Direct) |
View |
| 2025-03-01 Exercise |
2025-03-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal CEO |
9,466 | $0 | 1,485,841 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
27,258 | $1.99 | 276,780 (Direct) |
View |
| 2025-03-01 Exercise |
2025-03-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
60,925 | $0 | 276,780 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Davis Hugh M. President and COO |
336,300 | $0 | 336,300 (Direct) |
View |
| 2025-02-01 Tax Withholding |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO |
3,559 | $2.48 | 2,631,818 (Direct) |
View |
| 2025-02-01 Exercise |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO |
9,467 | $0 | 2,631,818 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO |
1,142,700 | $0 | 2,631,818 (Direct) |
View |
| 2025-02-01 Tax Withholding |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
11,317 | $2.48 | 668,838 (Direct) |
View |
| 2025-02-01 Exercise |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
22,250 | $0 | 668,838 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
377,400 | $0 | 668,838 (Direct) |
View |
| 2025-02-01 Tax Withholding |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
5,816 | $2.48 | 530,410 (Direct) |
View |
| 2025-02-01 Exercise |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
14,750 | $0 | 530,410 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
396,300 | $0 | 530,410 (Direct) |
View |
| 2025-02-01 Tax Withholding |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
15,447 | $2.48 | 549,606 (Direct) |
View |
| 2025-02-01 Exercise |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
33,500 | $0 | 549,606 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
375,800 | $0 | 549,606 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
91,130 | $0 | 382,959 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
41,851 | $0 | 382,959 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
52,667 | $0 | 382,959 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
38,221 | $2.48 | 236,476 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
94,450 | $0 | 236,476 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
40,000 | $0 | 236,476 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
40,664 | $2.48 | 250,853 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
91,900 | $0 | 250,853 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
55,000 | $0 | 250,853 (Direct) |
View |
| 2025-01-01 Tax Withholding |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO |
17,436 | $2.48 | 1,640,194 (Direct) |
View |
| 2025-01-01 Exercise |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO |
38,616 | $0 | 1,640,194 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO |
88,333 | $0 | 1,640,194 (Direct) |
View |
| 2024-12-10 Gift |
2024-12-12 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
15,000 | $0 | 171,976 (Direct) |
View |
| 2024-12-04 Exercise |
2024-12-06 4:15 pm |
N/A 2024-12-07 |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO |
118,840 | $0 | 1,433,630 (Direct) |
View |
| 2024-12-04 Tax Withholding |
2024-12-06 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO |
68,343 | $3.76 | 1,433,630 (Direct) |
View |
| 2024-12-04 Exercise |
2024-12-06 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO |
118,840 | $1.52 | 1,433,630 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-03 5:42 pm |
N/A 2034-12-01 |
Aclaris Therapeutics Inc. | ACRS | Davis Hugh M. President and COO |
482,000 | $0 | 482,000 (Direct) |
View |
| 2024-12-01 Tax Withholding |
2024-12-03 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO |
2,721 | $4.07 | 1,430,467 (Direct) |
View |
| 2024-12-01 Exercise |
2024-12-03 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM CEO |
9,466 | $0 | 1,430,467 (Direct) |
View |
Ownership |
2024-11-25 11:03 am |
2024-11-18 N/A |
Aclaris Therapeutics Inc. | ACRS | Biosion Inc. 10% Owner |
0 | $0 | 11,281,985 (Direct) |
View |
| 2024-11-01 Tax Withholding |
2024-11-05 4:20 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
2,721 | $2.09 | 1,433,188 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 4:20 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
9,467 | $0 | 1,433,188 (Direct) |
View |
| 2024-10-01 Exercise |
2024-10-03 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
9,467 | $0 | 1,435,909 (Direct) |
View |
| 2024-10-01 Tax Withholding |
2024-10-03 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
2,722 | $1.18 | 1,435,909 (Direct) |
View |
| 2024-09-01 Exercise |
2024-09-04 7:52 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
1,000 | $0 | 24,697 (Direct) |
View |
| 2024-09-01 Tax Withholding |
2024-09-04 7:52 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
286 | $1.18 | 24,697 (Direct) |
View |
| 2024-09-01 Exercise |
2024-09-04 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
9,466 | $0 | 1,438,631 (Direct) |
View |
| 2024-09-01 Tax Withholding |
2024-09-04 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
2,722 | $1.18 | 1,438,631 (Direct) |
View |
| 2024-08-09 Exercise |
2024-08-13 4:15 pm |
N/A 2024-08-12 |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
43,548 | $0 | 1,356,153 (Direct) |
View |
| 2024-08-09 Exercise |
2024-08-13 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
43,548 | $0.72 | 1,356,153 (Direct) |
View |
| 2024-08-01 Tax Withholding |
2024-08-05 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
2,722 | $1.32 | 1,397,805 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-05 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
9,467 | $0 | 1,397,805 (Direct) |
View |
| 2024-07-01 Exercise |
2024-07-03 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
9,467 | $0 | 1,400,527 (Direct) |
View |
| 2024-07-01 Tax Withholding |
2024-07-03 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
2,722 | $1.15 | 1,400,527 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:15 pm |
N/A 2034-06-05 |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
20,543 | $0 | 20,543 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:15 pm |
N/A 2034-06-05 |
Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director |
20,543 | $0 | 20,543 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:15 pm |
N/A 2034-06-05 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
20,543 | $0 | 20,543 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:15 pm |
N/A 2034-06-05 |
Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director |
20,543 | $0 | 20,543 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:15 pm |
N/A 2034-06-05 |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
20,543 | $0 | 20,543 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:15 pm |
N/A 2034-06-05 |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
20,543 | $0 | 20,543 (Direct) |
View |